Levels of Metals in the Blood and Specific Porphyrins in the Urine in Children with Autism Spectrum Disorders

被引:0
作者
Marta Macedoni-Lukšič
David Gosar
Geir Bjørklund
Jasna Oražem
Jana Kodrič
Petra Lešnik-Musek
Mirjana Zupančič
Alenka France-Štiglic
Alenka Sešek-Briški
David Neubauer
Joško Osredkar
机构
[1] University Paediatric Hospital,
[2] Institute of Autism Spectrum Disorders,undefined
[3] Council for Nutritional and Environmental Medicine,undefined
[4] University Institute for Clinical Chemistry and Biochemistry,undefined
[5] University Clinical Centre,undefined
来源
Biological Trace Element Research | 2015年 / 163卷
关键词
Autism; Neurodevelopmental; Children; Metals; Zinc; Copper;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to determine the levels of metals in blood (zinc (Zn), copper (Cu), aluminium (Al), lead (Pb) and mercury (Hg)), as well as the specific porphyrin levels in the urine of patients with autism spectrum disorder (ASD) compared with patients with other neurological disorders. The study was performed in a group of children with ASD (N = 52, average age = 6.2 years) and a control group of children with other neurological disorders (N = 22, average age = 6.6 years), matched in terms of intellectual abilities (Mann-Whitney U = 565.0, p = 0.595). Measurement of metals in blood was performed by atomic absorption spectrometry, while the HPLC method via a fluorescence detector was used to test urinary porphyrin levels. Results were compared across groups using a multivariate analysis of covariance (MANCOVA). In addition, a generalized linear model was used to establish the impact of group membership on the blood Cu/Zn ratio. In terms of blood levels of metals, no significant difference between the groups was found. However, compared to the control group, ASD group had significantly elevated blood Cu/Zn ratio (Wald χ2 = 6.6, df = 1, p = 0.010). Additionally, no significant difference between the groups was found in terms of uroporphyrin I, heptacarboxyporphyrin I, hexacarboxyporphyrin and pentacarboxyporphyrin I. However, the levels of coproporphyrin I and coproporphyrin III were lower in the ASD group compared to the controls. Due to observed higher Cu/Zn ratio, it is suggested to test blood levels of Zn and Cu in all autistic children and give them a Zn supplement if needed.
引用
收藏
页码:2 / 10
页数:8
相关论文
共 302 条
[1]  
Fombonne E(2008)Principal Investigators; Centers for Disease Control and Prevention (2012) Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008 MMWR Surveill Summ 61 1-19
[2]  
King M(2009)Commentary: on King and Bearman Int J Epidemiol 38 1241-1242
[3]  
Bearman P(2009)Diagnostic change and the increased prevalence of autism Int J Epidemiol 38 1224-1234
[4]  
Sinzig J(2009)Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome? J Atten Disord 13 117-126
[5]  
Walter D(2010)Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity? J Autism Dev Disord 40 580-589
[6]  
Doepfner M(2011)Genetic heritability and shared environmental factors among twin pairs with autism Arch Gen Psychiatry 68 1095-1102
[7]  
Anholt GE(2005)Aetiology of autism: findings and questions J Intellect Disabil Res 49 231-238
[8]  
Cath DC(2012)A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder Hum Genet 131 565-79
[9]  
van Oppen P(2012)Genetic architecture in autism spectrum disorder Curr Opin Genet Dev 22 229-237
[10]  
Eikelenboom M(2006)The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism Environ Health Perspect 114 1119-1125